Horizon Therapeutics PLC has gained approval for its thyroid eye disease treatment Tepezza (teprotumumab-trbw) from the US Food and Drug Administration, six weeks ahead of schedule.
The Dublin, Ireland-domiciled company has gained notoriety in recent years, thanks to its practice of buying up established drugs and...